{"disease":{"id":"dependence","name":"dependence"},"drugs":{"marketed":[{"drug_id":"buprenorphine","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Subutex","generic_name":"BUPRENORPHINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"mu-opioid receptor, kappa-opioid receptor","drug_class":"Partial Opioid Agonist","quality_score":75,"revenue":"800","mechanism":"Buprenorphine binds to mu-opioid receptors as a partial agonist and kappa-opioid receptors as an antagonist."},{"drug_id":"buprenorphine","indication_name":"Opioid Dependence Treatment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Subutex","generic_name":"BUPRENORPHINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"mu-opioid receptor, kappa-opioid receptor","drug_class":"Partial Opioid Agonist","quality_score":75,"revenue":"800","mechanism":"Buprenorphine binds to mu-opioid receptors as a partial agonist and kappa-opioid receptors as an antagonist."},{"drug_id":"buprenorphine-hydrochloride","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Subutex","generic_name":"Buprenorphine Hydrochloride","company_name":"Indivior","drug_phase":"marketed","molecular_target":"mu-opioid receptor, kappa-opioid receptor","drug_class":"partial opioid agonist","quality_score":75,"revenue":"800","mechanism":"Buprenorphine is a partial agonist at mu-opioid receptors and antagonist at kappa-opioid receptors."},{"drug_id":"naloxone","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"levomethadone","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"LEVOMETHADONE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"levomethadone","quality_score":null,"revenue":null,"mechanism":"LEVOMETHADONE works by binding to opioid receptors in the brain, reducing withdrawal symptoms and cravings."},{"drug_id":"nicotine","indication_name":"Nicotine dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nicorette","generic_name":"NICOTINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha4/beta2","drug_class":"Cholinergic Nicotinic Agonist [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levomethadyl-acetate","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Orlaam","generic_name":"LEVOMETHADYL ACETATE","company_name":"Roxane","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"High Risk QT Prolonging Agents","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"wellbutrin","indication_name":"Nicotine dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Wellbutrin","company_name":"Mclean Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"elontril","indication_name":"Nicotine dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Elontril","company_name":"Boehringer Ingelheim","drug_phase":"phase_3","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bupropion","indication_name":"Nicotine dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wellbutrin","generic_name":"bupropion","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor","drug_class":"NDRI (Norepinephrine-dopamine reuptake inhibitor)","quality_score":55,"revenue":null,"mechanism":"Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects."},{"drug_id":"methadone","indication_name":"Temporary Treatment of Opioid Dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadone Hydrochloride","generic_name":"METHADONE","company_name":"Specgx Llc","drug_phase":"marketed","molecular_target":"mu-opioid receptors, NMDA receptor","drug_class":"Opioid Agonist","quality_score":66,"revenue":null,"mechanism":"Methadone is a synthetic opioid that acts as a mu-agonist, providing analgesia and aiding in opioid addiction management."},{"drug_id":"acetylmethadol","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadyl","generic_name":"acetylmethadol","company_name":"","drug_phase":"unknown","molecular_target":"Mu-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Methadyl works by blocking potassium channels in the brain to stabilize neuronal activity and reduce withdrawal symptoms."}],"pipeline":[{"drug_id":"0-5mg-varenicline-b-i-d","indication_name":"Tobacco Dependence","indication_type":"pipeline","phase":"preclinical","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"0.5mg Varenicline b.i.d.","generic_name":"0-5mg-varenicline-b-i-d","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"","drug_class":"Varenicline is classified as a selective nicotine receptor partial agonist (SNRPA) that works both t","quality_score":null,"revenue":null,"mechanism":"Varenicline is classified as a selective nicotine receptor partial agonist (SNRPA) that works both t"},{"drug_id":"1-0mg-varenicline-b-i-d","indication_name":"Tobacco Dependence","indication_type":"pipeline","phase":"preclinical","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"1.0mg Varenicline b.i.d.","generic_name":"1-0mg-varenicline-b-i-d","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"","drug_class":"Varenicline is classified as a selective nicotine receptor partial agonist (SNRPA) that works both t","quality_score":null,"revenue":null,"mechanism":"Varenicline is classified as a selective nicotine receptor partial agonist (SNRPA) that works both t"}],"offLabel":[],"totalMarketed":12,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT04506528","title":"COVID EHR COHORT at the University of Wisconsin","phase":"","overall_status":"COMPLETED","enrollment_count":1634381,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT05917691","title":"Impact of Functional Status on 30-day Resource Utilization and Organ System Complications Following Bariatric Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":65627,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT02425345","title":"Women's Health Initiative Strong and Healthy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":49331,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT04336605","title":"Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents","phase":"","overall_status":"UNKNOWN","enrollment_count":25000,"lead_sponsor_name":"Norwegian Center for Violence and Traumatic Stress Studies","has_results":false},{"nct_id":"NCT07466784","title":"CEDRN: Opioid Registry","phase":"","overall_status":"RECRUITING","enrollment_count":7200,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04743024","title":"TREAT Child Alcohol Use Disorder (C-AUD) in Eastern Uganda","phase":"","overall_status":"UNKNOWN","enrollment_count":7188,"lead_sponsor_name":"University of Bergen","has_results":false},{"nct_id":"NCT02773836","title":"European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Diseases (EUREST-PLUS)","phase":"","overall_status":"COMPLETED","enrollment_count":6036,"lead_sponsor_name":"European Network For Smoking and Tobacco Prevention","has_results":true},{"nct_id":"NCT01882348","title":"Changing Pediatric Office Systems Nationally to Address Parental Tobacco Use","phase":"NA","overall_status":"COMPLETED","enrollment_count":3888,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01052675","title":"Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":3180,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03196102","title":"Evaluation of a Brief Tobacco Intervention in the US Military","phase":"NA","overall_status":"COMPLETED","enrollment_count":2999,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT05678036","title":"Effects on Mortality and Clinical Course of a Patient's Choice Model for Opioid Maintenance Treatment for Opioid Dependence - Evaluation of a System Enabling a Large Expansion of Treatment Providers and Treatment Access","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT04737031","title":"Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke","phase":"NA","overall_status":"COMPLETED","enrollment_count":2146,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":true},{"nct_id":"NCT06901713","title":"Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Sir Run Run Shaw Hospital","has_results":false},{"nct_id":"NCT03194958","title":"Helping Poor Smokers Quit","phase":"NA","overall_status":"COMPLETED","enrollment_count":1944,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT05897788","title":"Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement","phase":"NA","overall_status":"RECRUITING","enrollment_count":1808,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT01571752","title":"Health Outcomes by Neighborhood - Baltimore","phase":"","overall_status":"COMPLETED","enrollment_count":1651,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT06881069","title":"Reach Through Equitable Implementation in Utah","phase":"NA","overall_status":"RECRUITING","enrollment_count":1560,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT03194919","title":"Negotiating a Quit Date or Not in Online Interventions","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT03191825","title":"Online Lapse Management Intervention","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT06909500","title":"A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1372,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT03134092","title":"The Life STORRIED Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1302,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT03176784","title":"UW Quitting Using Intensive Treatment Study (QUITS)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1251,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":true},{"nct_id":"NCT05515354","title":"Smoking Cessation and Menstrual Cycle Phase","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT02355665","title":"Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1198,"lead_sponsor_name":"McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.","has_results":true},{"nct_id":"NCT00106093","title":"Alcoholism Assessment and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":1192,"lead_sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","has_results":false},{"nct_id":"NCT02377726","title":"Anonymous Treatment on the Internet for Alcohol Dependence: A Randomised, Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":1170,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT06587737","title":"Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1125,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT02108080","title":"Characterization Imaging Instruments in Alcoholics and Non-Alcoholics","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","has_results":false},{"nct_id":"NCT01036581","title":"Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT02146911","title":"The MATCH (Medication Aids for Tobacco Cessation and Health) Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT06163872","title":"Doctors' Perspective on Tobacco Addiction","phase":"","overall_status":"COMPLETED","enrollment_count":941,"lead_sponsor_name":"Karadeniz Technical University","has_results":false},{"nct_id":"NCT03937180","title":"Blended Care for the Discontinuation of Benzodiazepine Use","phase":"NA","overall_status":"COMPLETED","enrollment_count":924,"lead_sponsor_name":"Kristien Coteur","has_results":false},{"nct_id":"NCT04832659","title":"Assessment of Biomarkers in Children to Help Parents Quit Tobacco","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":865,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05066126","title":"Mixed Presentation on Social Media","phase":"NA","overall_status":"COMPLETED","enrollment_count":828,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT01603992","title":"Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms","phase":"","overall_status":"COMPLETED","enrollment_count":822,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT02905734","title":"Nicotine Replacement Therapy in Nicotine-dependent Arrestees","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05487807","title":"Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT05281172","title":"Guided Self-Change Prevention Program for Alcohol Abuse in Adolescents in Educational Settings","phase":"NA","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Universidad Miguel Hernandez de Elche","has_results":false},{"nct_id":"NCT06262958","title":"Recognition and Early Intervention for Alcohol and Substance Abuse in Adolescence in Adolescent","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT03272685","title":"Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":799,"lead_sponsor_name":"University of Minnesota","has_results":true},{"nct_id":"NCT04805515","title":"Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior","phase":"NA","overall_status":"COMPLETED","enrollment_count":794,"lead_sponsor_name":"University of Vermont","has_results":true},{"nct_id":"NCT05513872","title":"Overcoming Nicotine Dependence to Enable Quitting","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":780,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT06129916","title":"Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":760,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT04281966","title":"Testing the Efficacy of the Ability School Engagement Partnership Program (ASEP)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":753,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT05221866","title":"Efficiency And Quality In Post-Surgical Pain Therapy After Discharge","phase":"NA","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"University of Nebraska","has_results":true},{"nct_id":"NCT03276767","title":"Comparing SMS and E-mail Reminders in an Online Smoking Cessation Intervention","phase":"NA","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT04738643","title":"Improving Tobacco Treatment Rates for Cancer Patients Who Smoke","phase":"NA","overall_status":"COMPLETED","enrollment_count":685,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":true},{"nct_id":"NCT02364947","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":678,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT03696888","title":"Skills-training for Reducing Risky Alcohol Use in App Form","phase":"NA","overall_status":"COMPLETED","enrollment_count":678,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT02357901","title":"Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Indivior Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}